Skip to main content
. Author manuscript; available in PMC: 2010 Nov 12.
Published in final edited form as: J Med Chem. 2009 Nov 12;52(21):6941–6945. doi: 10.1021/jm9004913

Table 2.

Opioid Agonist or Antagonist activities of Bcp1- and Dbcp1-Analogues of TIPP peptidesa

MVD
GPI
No. Peptide IC50 (nM) Keδ (nM) IC50 (nM) Keμ (nM)
1 H-Bcp-Tic-Phe-Phe-OH 3.42 ± 0.36 223 ± 37 (IC40)b
2 H-Bcp-Tic-Phe-OH 18.7 ± 1.2 458 ± 73 (IC35)b
3 H-Bcp-Tic-OH 17.8 ± 0.7 5380 ± 380
4 H-Bcp-TicΨ[CH2NH]Phe-Phe-OH 11.8 ± 1.6 (IC40)b 1460 ± 310 (IC40)b
5 H-Bcp-TicΨ[CH2NH]Cha-Phe-OH 32.0 ± 8.2 (IC40)b 721 ± 78 (IC35)b
6 H-Dbcp-Tic-Phe-Phe-OH 3.07 ± 0.51 373 ± 71
7 H-Dbcp-Tic-OH 1.76 ± 0.30 2910 ± 570
8 H-Tyr-Tic-Phe-Phe-OH (TIPP)c 4.80 ± 0.20 > 10000
9 H-Tyr-Tic-OH 263 ± 40 inactive
10 H-Dmt-Tic-Phe-Phe-OHc 0.196 ± 0.035 769 ± 142
11 H-Dmt-Tic-OHc 6.55 ± 0.27 inactive
12 H-Cdp-Tic-Phe-Phe-OH 0.627 ± 0.058 3070 ± 260
a

Values represent means of 3–6 determinations.

b

Partial agonist.

c

Data taken from Schiller et al.10